Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the tumor microenvironment and adjacent lymph nodes.